Exact Sciences Corporation (BIT:1EXAS)
Italy flag Italy · Delayed Price · Currency is EUR
44.91
-1.32 (-2.86%)
At close: Jul 16, 2025

Exact Sciences Company Description

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally.

It offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer.

The company also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Riskguard Test, a hereditary cancer test to understand their inherited risk of cancer.

Its pipeline focus on advancing screening and diagnostic products, including risk assessment, screening and prevention, early disease diagnosis, adjuvant and/or neoadjuvant disease treatment, metastatic disease treatment selection, and recurrence monitoring.

The company has license agreements with MAYO Foundation for Medical Education and Research and Johns Hopkins University.

Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.

Exact Sciences Corporation
CountryUnited States
Founded1995
IndustryCommercial Physical and Biological Research
Employees7,000
CEOKevin Conroy

Contact Details

Address:
5505 Endeavor Lane
Madison, Delaware 53719
United States
Phone608 284 5700
Websiteexactsciences.com

Stock Details

Ticker Symbol1EXAS
ExchangeBorsa Italiana
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
SIC Code8731

Key Executives

NamePosition
Kevin ConroyChief Executive Officer
Aaron BloomerChief Financial Officer
Derek LeckowHead of Investor Relations